CA2392955A1 - Substituted 1,2,3-triazolo[1,5-a]quinazolines for enhancing cognition - Google Patents

Substituted 1,2,3-triazolo[1,5-a]quinazolines for enhancing cognition Download PDF

Info

Publication number
CA2392955A1
CA2392955A1 CA002392955A CA2392955A CA2392955A1 CA 2392955 A1 CA2392955 A1 CA 2392955A1 CA 002392955 A CA002392955 A CA 002392955A CA 2392955 A CA2392955 A CA 2392955A CA 2392955 A1 CA2392955 A1 CA 2392955A1
Authority
CA
Canada
Prior art keywords
nitrogen
atoms
4alkyl
optionally
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002392955A
Other languages
English (en)
French (fr)
Inventor
Helen Jane Bryant
Mark Stuart Chambers
Philip Jones
Angus Murray Macleod
Robert James Maxey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon Pharma UK Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2392955A1 publication Critical patent/CA2392955A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CA002392955A 1999-12-14 2000-12-11 Substituted 1,2,3-triazolo[1,5-a]quinazolines for enhancing cognition Abandoned CA2392955A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9929569.3A GB9929569D0 (en) 1999-12-14 1999-12-14 Therapeutic agents
GB9929569.3 1999-12-14
PCT/GB2000/004752 WO2001044250A1 (en) 1999-12-14 2000-12-11 SUBSTITUTED 1,2,3-TRIAZOLO[1,5-a]QUINAZOLINES FOR ENHANCING COGNITION

Publications (1)

Publication Number Publication Date
CA2392955A1 true CA2392955A1 (en) 2001-06-21

Family

ID=10866311

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002392955A Abandoned CA2392955A1 (en) 1999-12-14 2000-12-11 Substituted 1,2,3-triazolo[1,5-a]quinazolines for enhancing cognition

Country Status (7)

Country Link
US (1) US7144887B2 (https=)
EP (1) EP1242423A1 (https=)
JP (1) JP2003516994A (https=)
AU (1) AU780554B2 (https=)
CA (1) CA2392955A1 (https=)
GB (1) GB9929569D0 (https=)
WO (1) WO2001044250A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0108475D0 (en) * 2001-04-04 2001-05-23 Merck Sharp & Dohme New compounds
EP2321285A1 (en) 2008-07-28 2011-05-18 F. Hoffmann-La Roche AG Diazepan and piperazine derivatives modulators of chemokine receptors
EP3034079B1 (en) 2010-11-15 2018-01-10 Agenebio, Inc. Pyridazine derivatives, compositions and methods for treating cognitive impairment
US20130237530A1 (en) * 2010-11-15 2013-09-12 Agenebio, Inc. Benzodiazepine derivatives, compositions and methods for treating cognitive impairment
US20150374705A1 (en) 2012-02-14 2015-12-31 Shanghai Institues for Biological Sciences Substances for treatment or relief of pain
MX2014014308A (es) * 2012-05-30 2015-02-12 Hoffmann La Roche Pirrolidino heterociclos.
NZ760341A (en) 2013-12-20 2021-12-24 Agenebio Inc Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
MX392119B (es) 2015-06-19 2025-03-11 Agenebio Inc Derivados de benzodiazepina, composiciones y metodos para tratar deterioro cognitivo
CN107344937A (zh) * 2016-05-06 2017-11-14 如东赛默罗生物科技有限公司 三唑并[1,5-a]喹唑啉类衍生物、其制备方法、药物组合物和用途
US11505555B2 (en) 2016-12-19 2022-11-22 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
US20180170941A1 (en) 2016-12-19 2018-06-21 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
CN112601749B (zh) 2018-06-19 2024-03-26 艾吉因生物股份有限公司 用于治疗认知损害的苯并二氮杂环庚三烯衍生物，组合物和方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH21834A (en) 1982-01-18 1988-03-17 Lepetit Spa New 6-substituted-s-triazolo(3,4-a)phthalazine derivatives
US5306819A (en) * 1992-08-27 1994-04-26 Neurogen Corporation Certain aryl a cycloalkyl fused imidazopyrazinols; and new class of GABA brain receptor ligands
DE19617862A1 (de) * 1996-04-23 1997-10-30 Schering Ag Phthalazinderivate, deren Herstellung und Verwendung als Arzneimittel
KR20000029548A (ko) 1996-07-25 2000-05-25 더블유. 지. 콜 가바수용체에대한리간드로서의치환된트리아졸로-피리다진유도체
CA2288789C (en) 1997-05-08 2009-07-21 Merck Sharp & Dohme Limited Substituted 1,2,4-triazolo[3,4-a]phthalazine derivatives as gaba alpha 5 ligands
GB9813006D0 (en) * 1998-06-16 1998-08-12 Merck Sharp & Dohme Therapeutic agents
GB9929687D0 (en) * 1999-12-15 2000-02-09 Merck Sharp & Dohme Therapeutic agents

Also Published As

Publication number Publication date
US7144887B2 (en) 2006-12-05
EP1242423A1 (en) 2002-09-25
GB9929569D0 (en) 2000-02-09
WO2001044250A1 (en) 2001-06-21
US20030125333A1 (en) 2003-07-03
AU2195401A (en) 2001-06-25
JP2003516994A (ja) 2003-05-20
AU780554B2 (en) 2005-03-24

Similar Documents

Publication Publication Date Title
US6200975B1 (en) Substituted 1,2,4-triazolo[3,4-a]phthalazine derivatives as GABA alpha 5 ligands
AU760688B2 (en) Pyrazolo-triazine derivatives as ligands for GABA receptors
AU723098B2 (en) Substituted triazolo-pyridazine derivatives as ligands for GABA receptors
TWI902864B (zh) 新穎二唑系選擇性ｈｄａｃ６抑制劑及其用途
AU745005B2 (en) Therapeutically active 1,2,4-triazolo(4.,3-b) pyridazine derivatives as ligands for gaba receptors
TW201136937A (en) Imidazopyrimidine derivatives
AU8663398A (en) Tricyclic vasopressin agonists
SK121498A3 (en) Quinoxalinediones, method and intermediates for their producing, use thereof and pharmaceutical compositions based thereupon
US6143773A (en) Substituted thienobenzisoxazole derivatives for enhancing cognition
AU780554B2 (en) Substituted 1,2,3-triazolo(1,5-a)quinazolines for enhancing cognition
US6900209B2 (en) Nitrogen substituted 1,2,4-triazolo[3,4-a]phthalazine derivatives for enhancing cognition
US6297235B1 (en) Triazolopyridazine derivatives for treating anxiety and enhancing cognition
US6355638B1 (en) Pyrazolo[1,5-d][1,2,4] triazines for enhancing cognition
US6613766B1 (en) Pentaaza-cyclopental[a]naphthalene derivatives as ligands for GABAa α5 receptors
MXPA99000990A (en) Substituted triazolo-pyridazine derivatives as ligands for gaba receptors

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued